Search Page
Save citations to file
Email citations
Email address has not been verified. Go to
My NCBI account settings
to confirm your email and then refresh this page.
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 2 |
2025 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
PD-L1 imaging with [99mTc]NM-01 SPECT/CT is associated with metabolic response to pembrolizumab with/without chemotherapy in advanced lung cancer.
Br J Cancer. 2025 Jun;132(10):913-921. doi: 10.1038/s41416-025-02991-w. Epub 2025 Apr 5.
Br J Cancer. 2025.
PMID: 40188291
Free PMC article.
Clinical Trial.
[99mTc]-labelled anti-Programmed Death-Ligand 1 single-domain antibody SPECT/CT: a novel imaging biomarker for myocardial PD-L1 expression.
Nazir MS, Hughes DJ, Chand G, Adamson K, Johnson J, Bailey D, Gibson V, Ting HH, Lyon AR, Cook GJR; PECan study group.
Nazir MS, et al.
EJNMMI Res. 2023 May 17;13(1):44. doi: 10.1186/s13550-023-00990-7.
EJNMMI Res. 2023.
PMID: 37195370
Free PMC article.
Item in Clipboard
Inter-rater and intra-rater agreement of [99mTc]-labelled NM-01, a single-domain programmed death-ligand 1 (PD-L1) antibody, using quantitative SPECT/CT in non-small cell lung cancer.
Hughes DJ, Chand G, Johnson J, Bailey D, Adamson K, Goh V, Cook GJR.
Hughes DJ, et al.
EJNMMI Res. 2023 May 31;13(1):51. doi: 10.1186/s13550-023-01002-4.
EJNMMI Res. 2023.
PMID: 37256434
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.